COVID Vaccine Advisory Committee: Be Careful What You Wish For
The US FDA has promised to hold a public advisory committee review before authorizing or approving any COVID-19 vaccine candidates. What could possibly go wrong?
You may also be interested in...
As US FDA recovers from aducanumab and looks towards an advisory committee on Pfizer’s COVID vaccine, it’s worth reflecting on how Office of Vaccine Research & Review Director Marion Gruber created positive turning points for the agency during a general discussion of vaccine approval standards at the VRBPAC.
With the meetings available on television, access can be assured for just about everyone, and the US FDA can avoid another gut punch to its credibility.
Meeting to address opioid abuse crisis was also a trial of whether FDA could conduct important public business using online-only technology.